4//SEC Filing
PLx Pharma Inc. 4
Accession 0001144204-17-021379
CIK 0001497504operating
Filed
Apr 19, 8:00 PM ET
Accepted
Apr 20, 9:15 PM ET
Size
7.4 KB
Accession
0001144204-17-021379
Insider Transaction Report
Form 4
PLx Pharma Inc.PLXP
Casale Robert
Director
Transactions
- Award
Common Stock
2017-04-19+2,710→ 2,710 total - Award
Options
2017-04-19+9,002→ 9,002 totalExercise: $12.44From: 2017-04-19Exp: 2025-07-22→ Common Stock (9,002 underlying)
Footnotes (2)
- [F1]Received in exchange for 3,442 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.).
- [F2]Received in connection with the Merger in exchange for an employee stock option to buy 11,429 shares of PLx Opco Inc. common stock for $9.80 per share.
Documents
Issuer
PLx Pharma Inc.
CIK 0001497504
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001497504
Filing Metadata
- Form type
- 4
- Filed
- Apr 19, 8:00 PM ET
- Accepted
- Apr 20, 9:15 PM ET
- Size
- 7.4 KB